Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$105.40
0.290.28%
al cierre: Nov 21, 4:00 PM EST
$103.75
-1.65-1.57%
Pre-comercialización: 7:18 AM EST
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NICE Ltd tiene un precio objetivo de consenso de $200.56 basado en las calificaciones de 18 analistas. El máximo es $300, emitido por JMP Securities el agosto 26, 2025. El mínimo es $130, emitido por DA Davidson el noviembre 18, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Citigroup, Barclays y DA Davidson el noviembre 19, 2025, noviembre 19, 2025 y noviembre 18, 2025, respectivamente. Con un precio objetivo promedio de $161.33 entre Citigroup, Barclays y DA Davidson, hay una 55.50% upside implícita para NICE Ltd según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Citigroup
Barclays
DA Davidson
Morgan Stanley
Jefferies
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NICE
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/19/2025 | 82.17% | Citigroup | $211 → $189 | Maintains | Buy | |||
11/19/2025 | 59.04% | Barclays | $200 → $165 | Maintains | Overweight | |||
11/18/2025 | 25.3% | DA Davidson | $150 → $130 | Maintains | Neutral | |||
11/18/2025 | 54.22% | Morgan Stanley | $193 → $160 | Maintains | Overweight | |||
11/18/2025 | 31.08% | Jefferies | $152 → $136 | Maintains | Hold | |||
11/18/2025 | 44.58% | Mizuho | $185 → $150 | Maintains | Outperform | |||
11/18/2025 | 68.67% | RBC Capital | $190 → $175 | Maintains | Outperform | |||
11/18/2025 | 28.19% | Cantor Fitzgerald | $154 → $133 | Maintains | Neutral | |||
11/18/2025 | 68.67% | Rosenblatt | $190 → $175 | Maintains | Buy | |||
11/14/2025 | 103.37% | Citigroup | $209 → $211 | Maintains | Buy | |||
11/14/2025 | 92.77% | Citizens | $300 → $200 | Maintains | Market Outperform | |||
10/13/2025 | 46.51% | Jefferies | → $152 | Reinstates | → Hold | |||
08/26/2025 | 189.16% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
08/15/2025 | 86.02% | Morgan Stanley | $202 → $193 | Maintains | Overweight | |||
08/15/2025 | 83.13% | Rosenblatt | $190 → $190 | Maintains | Buy | |||
08/14/2025 | 44.58% | DA Davidson | $195 → $150 | Maintains | Neutral | |||
07/29/2025 | 189.16% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
07/28/2025 | 87.95% | DA Davidson | → $195 | Assumes | → Neutral | |||
06/20/2025 | 87.95% | DA Davidson | $185 → $195 | Maintains | Buy | |||
06/20/2025 | 92.77% | Wedbush | $200 → $200 | Reiterates | Outperform → Outperform | |||
06/18/2025 | 92.77% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
06/18/2025 | 55.18% | Cantor Fitzgerald | $161 → $161 | Reiterates | Neutral → Neutral | |||
06/18/2025 | 189.16% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
06/18/2025 | 83.13% | Rosenblatt | $190 → $190 | Maintains | Buy | |||
06/13/2025 | 75.42% | Piper Sandler | $153 → $182 | Maintains | Neutral | |||
05/19/2025 | 103.37% | Citigroup | $214 → $211 | Maintains | Buy | |||
05/16/2025 | 92.77% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
05/16/2025 | 189.16% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
05/16/2025 | 78.31% | DA Davidson | $180 → $185 | Maintains | Buy | |||
05/16/2025 | 55.18% | Cantor Fitzgerald | $161 → $161 | Reiterates | Neutral → Neutral | |||
05/16/2025 | 92.77% | Wedbush | $200 → $200 | Reiterates | Outperform → Outperform | |||
05/16/2025 | 83.13% | Rosenblatt | $180 → $190 | Maintains | Buy | |||
04/24/2025 | 73.49% | Rosenblatt | $200 → $180 | Maintains | Buy | |||
04/16/2025 | 94.7% | Morgan Stanley | $235 → $202 | Maintains | Overweight | |||
04/14/2025 | 73.49% | DA Davidson | $200 → $180 | Maintains | Buy | |||
03/19/2025 | 92.77% | RBC Capital | $200 → $200 | Reiterates | Outperform → Outperform | |||
02/24/2025 | 119.76% | Citigroup | $279 → $228 | Maintains | Buy | |||
02/21/2025 | 92.77% | Wedbush | $250 → $200 | Maintains | Outperform | |||
02/21/2025 | 92.77% | RBC Capital | $260 → $200 | Maintains | Outperform | |||
02/21/2025 | 55.18% | Cantor Fitzgerald | $176 → $161 | Maintains | Neutral | |||
02/21/2025 | 189.16% | Citizens Capital Markets | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
02/21/2025 | 92.77% | Rosenblatt | $225 → $200 | Maintains | Buy | |||
02/21/2025 | 117.83% | Barclays | $286 → $226 | Maintains | Overweight | |||
02/18/2025 | 168.92% | Citigroup | $315 → $279 | Maintains | Buy | |||
01/16/2025 | 69.64% | Cantor Fitzgerald | → $176 | Initiates | → Neutral | |||
12/19/2024 | 92.77% | Jefferies | $215 → $200 | Downgrade | Buy → Hold | |||
11/15/2024 | 107.23% | Jefferies | $230 → $215 | Maintains | Buy | |||
11/15/2024 | 116.87% | DA Davidson | $300 → $225 | Maintains | Buy | |||
11/15/2024 | 150.6% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
11/15/2024 | 140.96% | Northland Capital Markets | $275 → $250 | Maintains | Outperform | |||
11/14/2024 | 80.24% | Piper Sandler | $213 → $187 | Downgrade | Overweight → Neutral | |||
11/13/2024 | 221.93% | Citigroup | $330 → $334 | Maintains | Buy | |||
10/03/2024 | 150.6% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
08/16/2024 | 140.96% | Wedbush | $250 → $250 | Reiterates | Outperform → Outperform | |||
08/16/2024 | 150.6% | RBC Capital | $230 → $260 | Maintains | Outperform | |||
08/16/2024 | 189.16% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
08/16/2024 | 165.06% | Northland Capital Markets | $305 → $275 | Maintains | Outperform | |||
08/16/2024 | 116.87% | Rosenblatt | $225 → $225 | Maintains | Buy | |||
08/13/2024 | 116.87% | Rosenblatt | $225 → $225 | Maintains | Buy | |||
07/25/2024 | 175.66% | Barclays | $320 → $286 | Maintains | Overweight | |||
07/10/2024 | 105.3% | Piper Sandler | $238 → $213 | Maintains | Overweight | |||
06/14/2024 | 131.33% | Morgan Stanley | $290 → $240 | Maintains | Overweight | |||
06/13/2024 | 193.98% | Northland Capital Markets | $305 → $305 | Maintains | Outperform | |||
06/12/2024 | 233.49% | Citigroup | $339 → $346 | Maintains | Buy | |||
06/12/2024 | 189.16% | JMP Securities | $300 → $300 | Reiterates | Market Outperform → Market Outperform | |||
06/12/2024 | 121.69% | RBC Capital | $265 → $230 | Maintains | Outperform | |||
06/12/2024 | 140.96% | Wedbush | → $250 | Reiterates | Outperform → Outperform | |||
06/12/2024 | 189.16% | DA Davidson | $300 → $300 | Maintains | Buy | |||
06/12/2024 | 116.87% | Rosenblatt | $285 → $225 | Maintains | Buy | |||
05/17/2024 | 155.42% | RBC Capital | $285 → $265 | Maintains | Outperform | |||
05/17/2024 | 121.69% | Jefferies | $280 → $230 | Maintains | Buy | |||
05/17/2024 | 189.16% | JMP Securities | $343 → $300 | Maintains | Market Outperform | |||
05/17/2024 | 169.88% | Mizuho | $300 → $280 | Maintains | Buy | |||
05/17/2024 | 160.24% | B of A Securities | $300 → $270 | Maintains | Buy | |||
05/15/2024 | 230.6% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
04/23/2024 | 174.7% | Rosenblatt | → $285 | Initiates | → Buy | |||
03/13/2024 | 189.16% | DA Davidson | $250 → $300 | Upgrade | Neutral → Buy | |||
03/12/2024 | 189.16% | DA Davidson | $250 → $300 | Upgrade | Neutral → Buy | |||
02/23/2024 | 230.6% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
02/23/2024 | 222.89% | Citigroup | $334 → $335 | Maintains | Buy | |||
02/23/2024 | 174.7% | RBC Capital | $238 → $285 | Maintains | Outperform | |||
02/23/2024 | 189.16% | Mizuho | $244 → $300 | Maintains | Buy | |||
02/23/2024 | 208.43% | Barclays | $283 → $320 | Maintains | Overweight | |||
02/23/2024 | 160.24% | Wedbush | $230 → $270 | Maintains | Outperform | |||
02/23/2024 | 189.16% | Oppenheimer | $225 → $300 | Maintains | Outperform | |||
02/21/2024 | 221.93% | Citigroup | $283 → $334 | Maintains | Buy | |||
02/01/2024 | 230.6% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
01/30/2024 | 189.16% | Northland Capital Markets | → $300 | Initiates | → Outperform | |||
01/22/2024 | 230.6% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
12/18/2023 | 230.6% | JMP Securities | $343 → $343 | Reiterates | Market Outperform → Market Outperform | |||
11/22/2023 | 129.4% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
11/17/2023 | 129.4% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
10/16/2023 | 112.05% | Morgan Stanley | $225 → $220 | Upgrade | Equal-Weight → Overweight | |||
10/09/2023 | 230.6% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
10/05/2023 | 129.4% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
10/05/2023 | 116.87% | Oppenheimer | $250 → $225 | Maintains | Outperform | |||
09/29/2023 | 83.13% | DA Davidson | → $190 | Initiates | → Neutral | |||
08/18/2023 | 129.4% | RBC Capital | → $238 | Reiterates | Outperform → Outperform | |||
08/18/2023 | 230.6% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform | |||
08/15/2023 | 225.78% | Citigroup | $278 → $338 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NICE (NICE)?
El último precio objetivo de NICE (NASDAQ:NICE) fue comunicado por Citigroup el noviembre 19, 2025. La firma de analistas fijó un precio objetivo para $189.00 que espera NICE a rise dentro de 12 meses (un posible 82.17% upside). 46 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NICE (NICE)?
La última calificación de analistas para NICE (NASDAQ:NICE) fue proporcionada por Citigroup, y NICE mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de NICE (NICE)?
La última revisión al alza de NICE Ltd se produjo en marzo 13, 2024, cuando DA Davidson elevó su precio objetivo a $300. DA Davidson anteriormente tenía a neutral para NICE Ltd.
¿Cuándo fue la última revisión a la baja de NICE (NICE)?
La última revisión a la baja de NICE Ltd se produjo en diciembre 19, 2024, cuando Jefferies cambió su precio objetivo de $215 a $200 para NICE Ltd.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NICE (NICE)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NICE, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NICE se registró el noviembre 19, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 19, 2026.
¿Es correcta la calificación de los analistas sobre NICE (NICE)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NICE (NICE) fue un mantuvo con un precio objetivo de $211.00 a $189.00. El precio actual al que cotiza NICE (NICE) es de $103.75, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.